Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply
Most people dont have this issue, but for those who do, it can feel unsettling. According to Hosam Hmoud, MD, cardiology fellow at Northwell Lenox Hill Hospital, while the research and clinical trials we have so far on Ozempic and other GLP-1s dont include heart palpitations or arrhythmias as side effects, some studies have actually shown the opposite
While the short-term benefits may seem appealing, the long-term risks are too significant to ignoreespecially when safer, better-understood alternatives are available
Diabetes 57 , 26032612 (2008)
(2020) 79(OCE2), E245
These drugs mimic the action of natural GLP-1, enhancing its beneficial effects on weight and blood sugar control